*Emergent BioSolutions [EBS] received a $400 million contract from the Department of Health and Human Services (HHS) to provide 18.75 million doses of the anthrax vaccine BioThrax through Sept. 2010 for the strategic national stockpile. Contract terms also include an additional $34 million if the Food and Drug Administration approves the company's pending supplement to its biologics license application to extend the shelf life of BioThrax from three years to four years. On top of all that, HHS will provide…
Briefing
SHARE:
